Macomics: Macomics and IOR Switzerland announce macrophage scientific collaboration in prostate cancer drug development
Macomics Ltd, a leader in macrophage drug discovery, announces that it has entered a scientific collaboration with Prof. Andrea Alimonti at IOR (Institute of Oncology Research), one of Switzerland's leading research
Read full article »
Macomics is an England-based biotechnology company that develops and commercializes immunotherapies for the treatment of cancer.
Read more